On July 2nd, China Association for Science and Technology released the list of "Kechuang  China" in 2023 at the 26th annual meeting. Chongqing Precision Biotech was selected into New Sharp Enterprise List, becoming one of the 50 companies on this list and the only innovative biopharmaceutical enterprise in west China.

In order to implement General Secretary Xi Jinping's important speech and spirit on science and technology innovation, focus on serving the needs and development of new industries in China, focus on tackling key technical problems in emerging frontier areas, and tap a number of cutting-edge technological achievements, potential science and technology enterprises, Industry-University-Research collaborative innovation organizations, and technology transfer and transformation talents, China Association for Science and Technology has created a list brand with both characteristics and leadership-"Kechuang China" series list.Since 2020, 230 items have been released in the list, including 150 items of the leading technology list, 50 items of the new and sharp enterprises list, 10 items of the financial innovation organization list and 20 items of the technology manager pioneer list.

Precision Biotech focuses on malignant tumor treatment, and has the core competitiveness of cutting-edge technology of gene and cell therapy and independent intellectual property rights. This selection indicates that the company has been recognized at the national level in scientific and technological innovation and achievement transformation. In the future, our company will continue to adhere to our mission of "innovation for health", accelerate the cultivation and transformation of new quality productivity of biological drugs, empower industrial innovation and development, and contribute ourselves to build a powerful China in science and technology !